Patent: 7,994,117
✉ Email this page to a colleague
Summary for Patent: 7,994,117
Title: | Thrombopoietic compounds |
Abstract: | The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal. |
Inventor(s): | Liu; Chuan-Fa (Longmont, CO), Feige; Ulrich (Newbury Park, CA), Cheetham; Janet C. (Montecito, CA) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) |
Application Number: | 12/404,047 |
Patent Claims: | see list of patent claims |
Details for Patent 7,994,117
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | NPLATE | romiplostim | For Injection | 125268 | 08/22/2008 | ⤷ Try a Trial | 2018-10-23 |
Amgen, Inc. | NPLATE | romiplostim | For Injection | 125268 | 10/17/2019 | ⤷ Try a Trial | 2018-10-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,994,117
Country | Patent Number | Estimated Expiration |
---|---|---|
Argentina | 020934 | ⤷ Try a Trial |
Austria | 348163 | ⤷ Try a Trial |
Australia | 1223900 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |